Low-dosage hydrate inhibitor solutions for gas and multiphase systems

Flow assurance

Low-Dosage Hydrate Inhibitors

Application-specific support for hydrate-risk management in suitable systems.

The challenge

Technology selection requires a detailed review of fluid composition, water cut, pressure, temperature, residence time and operating strategy. Hydrate risk is strongly influenced by the pressure–temperature profile, free-water availability, gas composition, cooling history and the duration of exposure inside the hydrate stability region.

Our approach

Low-dosage hydrate inhibitors can help manage hydrate risk in suitable gas and multiphase systems. Depending on the application, the technical review may consider kinetic hydrate inhibitor or anti-agglomerant approaches, chemical compatibility, treatment dosage and the required operating window before field evaluation.

Typical applications

  • Suitable gas and multiphase systems

Technical support

  • Operating-condition and hydrate-risk review
  • KHI or anti-agglomerant technology screening where appropriate
  • Compatibility, dosage and operating-window review
  • Performance criteria and evaluation planning

Product availability, chemistry, concentration, packaging and regulatory status may vary by market and application. Final recommendations are subject to technical and commercial review.

Let’s discuss your requirement

Bring us your
chemical challenge.

Tell us about your application, technical challenge or sourcing requirement.

Talk to our technical team